401 related articles for article (PubMed ID: 2123553)
1. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
Bierer BE; Mattila PS; Standaert RF; Herzenberg LA; Burakoff SJ; Crabtree G; Schreiber SL
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9231-5. PubMed ID: 2123553
[TBL] [Abstract][Full Text] [Related]
2. Probing immunosuppressant action with a nonnatural immunophilin ligand.
Bierer BE; Somers PK; Wandless TJ; Burakoff SJ; Schreiber SL
Science; 1990 Oct; 250(4980):556-9. PubMed ID: 1700475
[TBL] [Abstract][Full Text] [Related]
3. The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines.
Hultsch T; Martin R; Hohman RJ
Mol Biol Cell; 1992 Sep; 3(9):981-7. PubMed ID: 1384815
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
[TBL] [Abstract][Full Text] [Related]
5. Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription.
Hultsch T; Albers MW; Schreiber SL; Hohman RJ
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6229-33. PubMed ID: 1712484
[TBL] [Abstract][Full Text] [Related]
6. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin.
Van Duyne GD; Standaert RF; Karplus PA; Schreiber SL; Clardy J
J Mol Biol; 1993 Jan; 229(1):105-24. PubMed ID: 7678431
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein.
Koltin Y; Faucette L; Bergsma DJ; Levy MA; Cafferkey R; Koser PL; Johnson RK; Livi GP
Mol Cell Biol; 1991 Mar; 11(3):1718-23. PubMed ID: 1996117
[TBL] [Abstract][Full Text] [Related]
8. Exon organization of the human FKBP-12 gene: correlation with structural and functional protein domains.
DiLella AG; Craig RJ
Biochemistry; 1991 Sep; 30(35):8512-7. PubMed ID: 1716149
[TBL] [Abstract][Full Text] [Related]
9. Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.
Sehgal SN
Ther Drug Monit; 1995 Dec; 17(6):660-5. PubMed ID: 8588237
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of a FKBP-type immunophilin from higher plants.
Luan S; Kudla J; Gruissem W; Schreiber SL
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6964-9. PubMed ID: 8692927
[TBL] [Abstract][Full Text] [Related]
11. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
Schwaninger M; Blume R; Oetjen E; Knepel W
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
[TBL] [Abstract][Full Text] [Related]
12. Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes.
Salowe SP; Hermes JD
Arch Biochem Biophys; 1998 Jul; 355(2):165-74. PubMed ID: 9675023
[TBL] [Abstract][Full Text] [Related]
13. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
Heitman J; Movva NR; Hall MN
Science; 1991 Aug; 253(5022):905-9. PubMed ID: 1715094
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
Rebollo A; Mérida I; Gómez J; Pitton C; Silva A; Martínez C; García A
Cytokine; 1995 Apr; 7(3):277-86. PubMed ID: 7543780
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond.
Zarnt T; Lang K; Burtscher H; Fischer G
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):159-64. PubMed ID: 7529995
[TBL] [Abstract][Full Text] [Related]
16. FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA.
Hanke JH; Nichols LN; Coon ME
Lymphokine Cytokine Res; 1992 Oct; 11(5):221-31. PubMed ID: 1281674
[TBL] [Abstract][Full Text] [Related]
17. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
Bierer BE; Schreiber SL; Burakoff SJ
Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
19. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
[TBL] [Abstract][Full Text] [Related]
20. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
